Skip to main content
Bloomberg Logo
Bloomberg

Articles by Bloomberg

Bloomberg

Samsung's Record Profit Fails to Impress After AI Chip Rally

For years, the Magnificent Seven tech giants commanded investors' attention, dominating the S&P 500 Index and determining which way the overall stock market was headed. Those days are over. While the technology-heavy Nasdaq 100 Index is up 16% in 2026 and the S&P 500 has climbed 10%, an index of the Mag 7 has gained just 1.7%. Ed Ludlow, BTech Anchor, addresses the top tech stories, including the Mag 7 struggling to keep a hold on the markets and Samsung's profit failing to impress.

Read more: Samsung's Record Profit Fails to Impress After AI Chip Rally
Bloomberg

AI Fuels Record M&A Boom

Record M&A volumes are being driven by AI, abundant capital, and a more deal-friendly regulatory environment, but Jones Day's Robert Profusek says private equity is still on the sidelines because sellers' expectations remain too high. He also warns that AI valuations are reaching unprecedented levels, raising questions about whether today's deal boom can last.

Read more: AI Fuels Record M&A Boom
Bloomberg

BlackRock's Bold AI Credit Call

BlackRock Investment Institute Global Head Jean Boivin joined Open Interest to talk about how AI is fueling the biggest investment transformation in history, making private credit one of the biggest long-term beneficiaries. He explains why investors don't need to pick AI winners to profit, why balance sheet quality matters more than ever, and why comparisons to the dot-com bubble or 2008 miss what's happening today.

Read more: BlackRock's Bold AI Credit Call
Bloomberg

Some Investors Rethink SpaceX Exposure

As SpaceX prepares to enter major indexes, wealth managers say clients are increasingly asking how to avoid owning the company because of Elon Musk's polarizing reputation.  Ellevest head of wealth management Emily Green joined Open Interest to discuss the  real cost of excluding stocks from index portfolios, why direct indexing is gaining traction, and what passive investors may not realize about changing index dynamics.

Read more: Some Investors Rethink SpaceX Exposure
Bloomberg

SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers

On this episode of Stock Movers: - Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv. - Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for $10 billion in cash to expand into endocrinology. - SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX's addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark.

Read more: SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers